Prescribing Hemodialysis (eBook)

A Guide to Urea Modeling

T.A. Depner (Autor)

eBook Download: PDF

2012
Springer US (Verlag)
978-1-4613-1509-4 (ISBN)

Infos

What regulation shall we have for the operation? Shall a man transfuse he knows not what. to correct he knows not what. God knows how (l)? Dr. Henry Stubbs Royal College of Physicians circa 1670 If dialysis therapy were a new phannaceutical product being evaluated by the FDA now, it might not be approved for marketing. The recommended dose, its potential toxicity, the side effects of under-or over-dialysis as well as its efficacy have been the subject of very few studies. The high mortality rate associated with the treatment may raise a few eyebrows. That it is a life-saving modality of treatment is undoubtedly true for more than 100,000 patients in the United States and for more than a million patients world- wide. Because dialysis has extended the lives of many people by a variable period of time, most nephrologists have "e;rested on their laurels"e; and did not vigorously pursue studies to optimize these treatments. But facts have a way of intruding in all our lives and the facts are that the overall mortality rate of dialysis patients in the United States is rising and stands close to 25% per year and is closer to 33% per year for patients between the ages of 65 and 74 (2). These mortality figures are considerably higher for age-adjusted dialysis populations in Europe and particu- larly in Japan, and certainly for the age-adjusted nonnal population.

Produkt-Details

• Erscheint lt. Verlag: 6.12.2012
• Sprache: englisch
• Themenwelt: Medizinische Fachgebiete ► Innere Medizin ► Nephrologie
• ISBN-10: 1-4613-1509-3 / 1461315093
• ISBN-13: 978-1-4613-1509-4 / 9781461315094